The Board of Trustees of the Leland Stanford Junior University;Myoforte Therapeutics Inc.
发明人:
Blau, Helen M.,Tri Van Ho, Andrew,Palla, Adelaida R.,Fishman, Harvey,Curtin, Catherine,Payne, Christopher,Delp, Scott,Shenoy, Vivek
申请号：
AU2018280264
公开号：
AU2018280264A1
申请日:
2018.06.08
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Provided herein are compositions for preventing or treating muscle conditions such as muscle damage, injury, or atrophy. In some embodiments, the compositions comprise a prostaglandin E2 (PGE2) compound and a myotoxin. In some embodiments, the muscle damage, injury, or atrophy is the result of a nerve injury, a surgical procedure, or a traumatic injury. Methods of promoting muscle regeneration and methods of increasing muscle mass are also provided herein.
